Medro's regular price is $199 a month for its compounded semaglutide; tirzepatide's is $299. A $99 code, applied automatically, cuts a new patient's first plan to $99 and $199. There's no membership.
$199 buys one month of compounded semaglutide, no commitment
No membership fee on top
Clean FDA warning-letter record
Names its pharmacy: The Pharmacy Hub
Against it
The advertised $99/mo is its lowest rung; plan on $199
No support hours published
What it is
Medro is a cash-pay telehealth brand, its name still marked “trademark pending,” whose catalog puts two compounded GLP-1s, semaglutide and tirzepatide, beside microdose versions of both, NAD+, sermorelin, glutathione and hair and sexual-health prescriptions. The intake is online with no appointment; a clinician reads it, and an approved order goes out by free expedited shipping.
Medro is blunt about its role: it runs the storefront and nothing clinical. Medro Health Technologies, Inc. owns the website and checkout, Seattle's Arora Health & Aesthetics, LLC supplies the clinicians (founder Dr. Sean Arora is listed as the provider), and The Pharmacy Hub in Miami fills prescriptions. Mail goes to a San Francisco suite, and the terms give a Dover, Delaware notice address and pick Delaware law.
The site's copy doesn't always line up. A scrolling banner on the home and About pages says “Branded medication only,” while every GLP-1 it prices is compounded and labeled as not FDA-approved.
What it actually costs
Advertised$99
Actually$199/mo
Medro advertises $99. A month costs $199 because the advertised rate is the lowest rung of a dose ladder.
The gap
They advertise $99 a month. That is the lowest rung, not the price most people pay; the number a reader should plan around is $199.
Semaglutide's regular price is $199 a month and tirzepatide's $299. The first plan gets $99 off through a code Medro applies for you, so a new patient's first semaglutide month costs $99 and the first tirzepatide month $199. No membership is required.
Dose shouldn't change the price, according to the GLP-1 page. The terms narrow that: introductory and first-month pricing isn't covered by any same-price offer, and Medro may reprice for supply, pharmacy cost, market conditions or operating costs.
Every figure starts with “From,” and the fine print says final pricing can vary by dose, supply duration and pharmacy pricing and is shown only once treatment is prescribed, before checkout. Nor is it settled what the price covers. The GLP-1 page speaks of one clear monthly price for medication, care and support, while Medro's own guide to starting GLP-1 care says “Medication cost is separate.”
Microdose plans cost less, from $119 (semaglutide) and $139 (tirzepatide).
The terms also describe a Weight Loss Guarantee Program that Medro “may offer” from time to time. Someone who completes 26 straight weekly doses, meets every requirement including two verification videos, and still hasn't lost 10% of their starting weight may get a refund or credit toward the first six months. No page says it's currently running.
Who it's wrong for
Budgeting from the $99? That's the first plan with a code; semaglutide's regular price is $199 a month, and tirzepatide's first-plan $199 becomes $299.
Shopping for Wegovy or Zepbound? Despite the “Branded medication only” banner, both of Medro's GLP-1s are compounded.
Changing your mind after checkout costs you here. Apart from a medical disqualification, the refund policy says no refund is issued when you cancel.
The exact charge stays hidden until late: final pricing appears “before checkout if treatment is prescribed,” and every listed figure is a “From” price.
Need a phone line with set hours? Medro prints a number but no hours, and sends clinical questions to its partner Arora Health rather than its own support team.
The American checks
Prescriber licensed in your state
Stated
Pharmacy named
The Pharmacy Hub, 15600 NW 15th Ave, Suite C, Miami, Florida.
What you get
Compounded semaglutide and tirzepatide, each with glycine and vitamin B12, “Compounded in the USA”. No brand-name GLP-1 is sold, although a banner on the home and About pages reads “Branded medication only”. The site doesn't say whether the pharmacy compounds under 503A or 503B.
Overseas fulfillment
None disclosed
Support hours
No phone hours are published; the GLP-1 page promises “unlimited 24/7 support”. Phone 925-453-9499, Medro's support email and chat in the patient portal.
What each check means, and what “Not stated” covers, is on how we review.
Questions people ask about Medro
How much does Medro cost a month?Month to month, compounded semaglutide is $199 a month and compounded tirzepatide $299. The $99 it advertises is the bottom of its price range.
Does Medro charge a membership fee?No. Medro bills compounded semaglutide at $199 a month with nothing added for a membership.
Does Medro sell compounded or brand-name GLP-1s?Compounded semaglutide and tirzepatide, each with glycine and vitamin B12, “Compounded in the USA”. No brand-name GLP-1 is sold, although a banner on the home and About pages reads “Branded medication only”. The site doesn't say whether the pharmacy compounds under 503A or 503B.
Which pharmacy fills Medro prescriptions?The Pharmacy Hub, 15600 NW 15th Ave, Suite C, Miami, Florida.
Has Medro received an FDA warning letter?No. FDA's published warning-letter index holds no letter to Medro on a search of “Medro”, “getmedro”, “Medro Health Technologies, Inc.”, “GetMedro”, “Arora Health & Aesthetics, LLC”, “Arora Health”, “The Pharmacy Hub”, and the search is linked under Sources.
Does GLP America earn money from Medro?No. Medro pays us nothing, and its $199 month sits where that price puts it. The Collective card on this page comes from a partner, which pays us a commission, and it's labeled Partner.
On the record10 sourcing notes: every price with the page it came from, and what the company doesn't publish
Sources: Medro's public site: Medro's home page, Medro's GLP-1 page (read with both the Semaglutide and Tirzepatide toggles selected), Medro's FAQ page, Medro's about page, Medro's contact page, Medro's medical provider page, Medro's refund policy page, Medro's terms page, Medro's what to know before starting GLP-1 care page and Medro's how online weight care works page. The intake at Medro's home page, the eligibility quiz and the patient portal at Medro's home page were not opened, and no email was entered.
The prices, from /glp1: the top banner “$99 off your first GLP-1 Treatment Plan”, the price card “Save flat $99 code auto-applied”, then with Semaglutide selected “From $99/mo, down from $199/mo” and with Tirzepatide selected “From $199/mo, down from $299/mo”. Beneath: “Same price every dose, with unlimited 24/7 support.”, “No Membership Required” and “Final pricing may vary by medication, dose, supply duration, availability, provider review, pharmacy pricing, and clinical eligibility. Final pricing is shown before checkout if treatment is prescribed.” Further down: “One price for any dose. Your price doesn't change.” and “Medro brings medication, care, and support together under one clear monthly price.” The home-page tiles read “Compounded Semaglutide From $99/mo”, “Compounded Tirzepatide From $199/mo”, “Microdose Semaglutide From $119/mo” and “Microdose Tirzepatide From $139/mo”.
What the price covers is described differently in Medro's blog post “What to Know Before Starting GLP-1 Care” (Apr 15, 2026): “Plan pricing covers the licensed provider review, ongoing care messaging, and fulfillment from a licensed pharmacy partner. Medication cost is separate and varies by what's prescribed.” The FAQ: “Is medication included in the listed price? This depends on the product and partner flow.” and “Do I need a membership? No. Medro does not require a membership at launch.”
Pricing conditions, from the terms (“Revision Date: May 17, 2026”): “Promotional offers, including “first month” offers, introductory discounts, or trial pricing, are not subject to “same price per dose” or “locked-in pricing” offers unless expressly stated in writing by Medro.” and “Medro reserves the right to adjust pricing from time to time in accordance with supply, pharmacy pricing, medication availability, market conditions, vendor pricing, regulatory requirements, operational costs, or other factors.”
Billing and refunds, from the Refund, Cancellation, and Returns Policy (“Revision Date: May 17, 2026”): the subscription “begins when you have completed the intake form, at which time you will be charged for the first month”; “if you are disqualified by our medical Provider for any medical reason, you will receive a full refund”; “we require your cancellation request to be received at least 72 hours prior to your billing date”; “Other than cancellation due to medical disqualification, IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES.” and “If approved, refunds will only be issued for your most recent billing cycle”.
The guarantee, from section 17 of the terms: “Medro may offer a Weight Loss Guarantee Program from time to time. If available, you may be eligible for a refund or program credit if, after strictly following the applicable program as prescribed and meeting all eligibility requirements, you do not lose 10% of your baseline body weight within six months.” It requires “26 consecutive weeks, totaling 26 doses without skipping any required doses” and two verification videos, and excludes oral forms.
Who does what: the FAQ says “No. Medro is not the medical provider.” and “Medro's clinical providers are Arora Health & Aesthetics, LLC ... Arora Health's office is located at 300 Lenora Street, Seattle, WA 98121.” The Medical Provider page adds “Provider: Dr. Sean Arora (NPI: 1841729449).” The pharmacy, from the FAQ: “Medro partners with The Pharmacy Hub, located at 15600 NW 15th Ave, Suite C, Miami, FL 33169.” and “The Pharmacy Hub states that it is licensed by state boards of pharmacy nationwide”. The blog post on GLP-1 care: “A clinician licensed in your state reviews your submission”.
The operator: the terms and refund policy name “Medro Health Technologies, Inc.”, with “Medro’s address for Notice is: Medro Health Technologies, Inc., 1252 Forrest Avenue, Dover, DE 19904” and a contact address of “2261 Market Street STE 18557, San Francisco, CA 94114”, phone 925-453-9499. Governing law is Delaware, with AAA arbitration. The footer: “Medro ™ (trademark pending)”.
Supply: the /glp1 FAQ says both drugs include “Additional ingredients (glycine and vitamin B12)” and are given as a weekly injection; the page badge says “Compounded in the USA”. The home and About page marquee repeats “Branded medication only” and “Free expedited shipping if prescribed”, while the home page's own disclaimer reads “Compounded medications are not approved by the FDA”.
No FDA enforcement action on record: FDA's warning-letter search on “Medro”, “getmedro”, “Medro Health Technologies, Inc.”, “GetMedro”, “Arora Health & Aesthetics, LLC”, “Arora Health”, “The Pharmacy Hub”, returns no letter addressed to Medro, its operator, the named pharmacies or Medro. Search FDA's warning letters.
The companies whose month of compounded semaglutide is closest in price to Medro's, membership included. Picked by price alone; whether a company pays us plays no part.